Evidence map›Paper›PMID 30084354›Full record

ArticleeLife2018

Pharmacologic ATF6 activating compounds are metabolically activated to selectively modify endoplasmic reticulum proteins.

Ryan Paxman, Lars Plate, Erik A Blackwood, Chris Glembotski, Evan T Powers, R Luke Wiseman, Jeffery W Kelly

Open access · goldAbstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Sestrin2 serves as a scaffold protein to maintain cardiac energy and metabolic homeostasis during pathological stress.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Review
  16. Article
  17. Thioredoxin Domain Containing 5 (TXNDC5): Friend or Foe?Current issues in molecular biology · 2024
    Review
  18. Article
  19. Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ryan PaxmanDepartment of Chemistry, The Scripps Research Institute, La Jolla, United States.ORCID 0000-0001-6421-1892
Lars PlateDepartment of Chemistry, The Scripps Research Institute, La Jolla, United States.ORCID 0000-0003-4363-6116
Erik A BlackwoodDepartment of Biology, San Diego State University, San Diego, United States.
Chris GlembotskiDepartment of Biology, San Diego State University, San Diego, United States.
Evan T PowersDepartment of Chemistry, The Scripps Research Institute, La Jolla, United States.ORCID 0000-0001-8185-8487
R Luke WisemanDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, United States.ORCID 0000-0001-9287-6840
Jeffery W KellyDepartment of Chemistry, The Scripps Research Institute, La Jolla, United States.ORCID 0000-0001-8943-3395
Scripps Research Institute · USSan Diego State University · US

Funding

Discovering small molecules activators of stress responsive signalingR01AG046495 · NIA · SCRIPPS RESEARCH INSTITUTE, THE · PI JEFFERY W KELLY, Rockland Luke Wiseman · 2013 to 2026
$6.0M
Establishing Strategies to Ameliorate Amyloid Pathology in Light Chain AmyloidosisR01DK107604 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI WISEMAN, ROCKLAND LUKE · 2016 to 2024
$4.3M
Direct Regulation of Extracellular Proteostasis by the Unfolded Protein ResponseR01NS092829 · NINDS · SCRIPPS RESEARCH INSTITUTE, THE · PI WISEMAN, ROCKLAND LUKE · 2015 to 2019
$2.1M
Role of the SR/ER E3 Ubiquitin Ligase Synoviolin 1 in Cardiac HypertrophyR01HL127439 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI GLEMBOTSKI, CHRIS · 2015 to 2018
$1.7M
Harnessing the Adaptive ER Stress Response in Myocardial IschemiaR01HL135893 · NHLBI · UNIVERSITY OF ARIZONA · PI GLEMBOTSKI, CHRIS · 2017 to 2020
$1.5M
Achievement Rewards for College Scientists Foundation San Diego chapterAmerican Heart Association 17PRES33670796Leukemia and Lymphoma Society 5439-16NHLBI NIH HHS R01 HL127439NHLBI NIH HHS R01 HL135893NIA NIH HHS R01 AG046495NIDDK NIH HHS R01 DK107604NIH HHS AG046495NIH HHS DK107604NIH HHS HL075573NIH HHS HL085577NIH HHS HL104535NINDS NIH HHS R01 NS092829San Diego State University Heart Institute Inamori FoundationSan Diego State University Rees-Stealy Research Foundation
6 · The paper itself

Abstract

Pharmacologic arm-selective unfolded protein response (UPR) signaling pathway activation is emerging as a promising strategy to ameliorate imbalances in endoplasmic reticulum (ER) proteostasis implicated in diverse diseases. The small molecule

Indexed as

Activating Transcription Factor 6AmidesEndoplasmic ReticulumEndoplasmic Reticulum StressHEK293 CellsHumansPhenylpropionatesProdrugsSignal TransductionSmall Molecule LibrariesUnfolded Protein ResponseActivating Transcription Factor 6AmidesATF6 protein, humanPhenylpropionatesProdrugsSmall Molecule Librariesbiochemistrychemical biologycytochrome p450humanprotein disulfide isomeraseproteostasisproteostasis regulatorquinone methidereactive cysteine

Identifiers

PMID30084354
PMCPMC6080950
OpenAlexW2887731941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.